Make your selection

List of Frankincense and group Cancer intersectionsRows: 21■ Human ■ Animal ■ Risk ■ Review

SubstanceConditionSeqSrc
PMID
Dtl
Title
Frankincense Bone Cancer
1
PM
32113150📋β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression
Frankincense Breast Cancer
7
PM
38194131📋The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer
Frankincense Breast Cancer
6
PM
36806721📋Evaluation of anticancer effects of frankincense on breast cancer stem-like cells
Frankincense Breast Cancer
4
PM
32595497📋Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology
Frankincense Breast Cancer
3
PM
31581678📋Comparative Investigation of Frankincense Nutraceuticals: Correlation of Boswellic and Lupeolic Acid Contents with Cytokine Release Inhibition and Toxicity against Triple-Negative Breast Cancer Cells
Frankincense Breast Cancer
2
PM
31181656📋Comparative Analysis of Pentacyclic Triterpenic Acid Compositions in Oleogum Resins of Different Boswellia Species and Their In Vitro Cytotoxicity against Treatment-Resistant Human Breast Cancer Cells
Frankincense Breast Cancer
5
PM
30314527📋Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling
Frankincense Breast Cancer
1
PM
29109091📋Transcriptomic Profiling of MDA-MB-231 Cells Exposed to Boswellia Serrata and 3-O-Acetyl-B-Boswellic Acid; ER/UPR Mediated Programmed Cell Death
Frankincense Cancer
3
PM
38816637📋Chemical Constituents and Pharmacological Properties of Frankincense: Implications for Anticancer Therapy
Frankincense Cancer
2
PM
36209562📋Anti-proliferative tirucallane triterpenoids from gum resin of Boswellia sacra
Frankincense Cancer
1
PM
26514509📋Phytochemical Analysis and Anti-cancer Investigation of Boswellia serrata Bioactive Constituents In Vitro
Frankincense Colorectal Cancer
2
PM
28549801📋Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells
Frankincense Colorectal Cancer
1
PM
28245338📋Boswellia serrata resin extract alleviates azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon tumorigenesis
Frankincense Leukemia
1
PM
38155908📋Boswellia carterii oleoresin extracts induce caspase-mediated apoptosis and G1 cell cycle arrest in human leukaemia subtypes
Frankincense Liver Cancer
3
PM
37719039📋Water extract of frankincense and myrrh inhibits liver cancer progression and epithelial‑mesenchymal transition through Wnt/β‑catenin signaling
Frankincense Liver Cancer
2
PM
35317323📋Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways
Frankincense Liver Cancer
1
PM
29784005📋CD8 + T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma
Frankincense Liver Cancer
4
PM
25177685📋Caspase mediated synergistic effect of Boswellia serrata extract in combination with doxorubicin against human hepatocellular carcinoma
Frankincense Lung Cancer
1
PM
31261510📋Integrative cancer treatment may have a survival benefit in patients with lung cancer: A retrospective cohort study from an integrative cancer center in Korea
Frankincense Multiple Myeloma
1
PM
32293402📋Frankincense and myrrh and their bioactive compounds ameliorate the multiple myeloma through regulation of metabolome profiling and JAK/STAT signaling pathway based on U266 cells
Frankincense Prostate Cancer
1
PM
38391402📋Phytotherapy Might Have a Role in Reducing Unnecessary Prostate Biopsies: Results from an Exploratory, Randomized Controlled Trial of Two Different Phytotherapeutic Agents